On the other hands, GPBAR1 has been recently identified as the physiological mediator of pruritus16, a common symptom observed in cholestasis and the severity of this side effect limits the pharmacological utility of dual agonists in the treatment of primary biliary cirrhosis (PBC) and related cholestatic disorders. The gene discussed is GPBAR1; the disease is primary biliary cholangitis.